Medtronic (MDT) 10-K Summary — Year Ended Apr 28, 2023
Medtronic reported a decline in annual revenue, with operating income and net income also noted. The company maintains a strong liquidity position with cash and credit facilities.
Key takeaway
Year ended Apr 28, 2023 · FY2025 10-K
Medtronic reported a decline in annual revenue, with operating income and net income also noted. The company maintains a strong liquidity position with cash and credit facilities.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$31.2B
Revenue reported for the fiscal year.
Operating income
$5.5B
Income from operations reported for the year.
Net income
$3.8B
Net income reported for the year.
Operating cash flow
$6B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Apr 29, 2022 | $31.7B | n/a |
| Apr 28, 2023 | $31.2B | -1.4% |
Business overview
The business overview section of the filing is not fully provided in the supplied excerpts. The company name identifies it as a medical technology firm, and the liquidity section indicates investments in research and development and property and equipment.
Financial performance
Annual revenue decreased compared to the prior year. Operating income and net income were reported, and cash provided by operating activities also declined.
Material risks
The supplied filing context does not include detailed descriptions of risk factors; the table of contents references them but no specific risks are provided.
Liquidity and capital
The company states it is in a strong financial position, with cash, equivalents, and investments sufficient for operating needs. Capital allocation priorities include dividends, share repurchases, debt service, and acquisitions.
What to watch
Monitor the trend in operating cash flow to assess the company's ability to generate cash from operations.